Liftstream is an executive search recruitment company in the life sciences sector
Dimension Therapeutics Diversifies Leadership with Management and Board Appointment
Dimension Therapeutics, a leading rare disease company advancing novel, liver-directed treatments for diverse genetic disorders has announced that it has expanded its Board of Directors with the elections of Georges Gemayel, Ph.D., former Executive Vice President of Genzyme Corporation, and Arlene M. Morris, former CEO of Syndax Pharmaceuticals. Dimension also announced that Donald J. Hayden, Jr., is leaving his position as a member of the Company’s Board of Directors.
Hans Schikan appointed Chairman of Complix
Complix, a biopharmaceutical company focused on developing a pipeline of transformative protein therapeutics, called Alphabodies™, mainly focused on oncology and autoimmune diseases, today announced the appointment of Hans Schikan as Chairman of its Board of Directors.
Wilson Therapeutics appoints Chief Medical Officer
Fresh from announcing that Hans Schikan, ex-CEO of Prosensa, would be joining the Board of Directors at Wilson Therapeutics, the company have announced the appointment of another Genzyme allumni, Dr. Carl Bjartmar as chief medical officer (CMO). Dr. Bjartmar will report to Jonas Hansson, chief executive officer, and will join the company’s management team.
Prosensa announces senior management and board appointments
Authored by Karl Simpson
Sanofi appoint Chief Patient Officer
Authored by James Sheppard
Fidelity Biosciences and REGENX launch new gene therapy company
Authored by James Sheppard
Osiris sells stem cell business in $100m deal
Authored by James Sheppard
Massachusetts biotech continues to excite with new investments
Authored by Karl Simpson
Isis gains milestone from GSK for rare disease trial and Aegerion takes them on in HoFH
Authored by Karl Simpson